Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion
NCT00227136 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2018-04-13
Summary
This is a research study looking at the effect of 5-Hydroxy Tryptophan (5-HTP) on urine excretion of 5-Hydroxyindolacetic acid (5-HIAA). 5-HTP is a common over the counter product that is sold in natural food stores and via the Internet. Increased levels of 5-HIAA in the urine can be found in a specific type of cancer, called carcinoid tumor. This study will examine the effect of oral 5-HTP intake on 5-HIAA excretion. Understanding this effect may help to determine which tests should be done in a patient with increased 5-HIAA excretion who's also taking 5-HTP.
Conditions
- Carcinoid Tumors
- Neuroendocrine Tumors
Interventions
- DRUG
-
5-Hydroxy-Tryptamine
Sponsors & Collaborators
-
University of Western Ontario, Canada
lead OTHER
Principal Investigators
-
Stan HM Van Uum, MD, PhD · Western University, Canada
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-05-31
- Completion
- 2005-09-30
Countries
- Canada
Study Locations
More Related Trials
-
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
NCT07220447 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Indole-3-Carbinol in Preventing Cancer in Healthy Participants
NCT00100958 ·Status: COMPLETED ·Phase: PHASE1
-
Symptom Burden in Head and Neck Cancer
NCT01219673 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Effects of Ginseng on Cancer-Related Fatigue
NCT01375114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Cancer Related Fatigue in Patients Receiving Chemotherapy
NCT00261534 ·Status: UNKNOWN
-
High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer
NCT00003623 ·Status: COMPLETED ·Phase: PHASE3
-
American Ginseng in Treating Patients With Cancer-Related Fatigue
NCT00182780 ·Status: COMPLETED ·Phase: NA
-
"Cancersensor": Circadian Rhythms
NCT01693835 ·Status: COMPLETED
-
Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy
NCT00379665 ·Status: COMPLETED ·Phase: PHASE2
-
Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
NCT00004154 ·Status: COMPLETED ·Phase: PHASE3
-
Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia
NCT00611650 ·Status: TERMINATED ·Phase: PHASE2
-
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
NCT01191216 ·Status: COMPLETED ·Phase: PHASE1
-
Improving Function,Welfare of Late-stage Cancer Subjects by ACC
NCT03057314 ·Status: TERMINATED ·Phase: PHASE1
-
Modafinil in Treating Fatigue in Patients With Cancer
NCT00112515 ·Status: UNKNOWN ·Phase: NA
-
Benzoylphenylurea in Treating Patients With Advanced Solid Tumors
NCT00016354 ·Status: COMPLETED ·Phase: PHASE1
-
UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors
NCT00036777 ·Status: COMPLETED ·Phase: PHASE1
-
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
NCT00378131 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan in Treating Aging Patients With Solid Tumors
NCT00026195 ·Status: COMPLETED ·Phase: PHASE1
-
Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer
NCT00178373 ·Status: COMPLETED ·Phase: PHASE2
-
Resveratrol in Healthy Adult Participants
NCT00721877 ·Status: COMPLETED ·Phase: PHASE1
-
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
NCT00088946 ·Status: COMPLETED ·Phase: PHASE2
-
Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer
NCT00033345 ·Status: COMPLETED ·Phase: PHASE1
-
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
NCT03996265 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
NCT02269267 ·Status: COMPLETED ·Phase: PHASE2
-
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
NCT00387504 ·Status: COMPLETED ·Phase: PHASE1